August 12th 2025
The target action date for the application is December 11, 2025.
Ophthalmologists update advisory on alpha-blockers
April 14th 2014The American Society of Cataract and Refractive Surgery and the American Academy of Ophthalmology have jointly issued an educational update about cataract surgery complications associated with systemic alpha-blockers based on the recent publication of two studies.
Liposomal botulinum shows promise for refractory OAB
April 11th 2014Intravesical administration of a liquid liposomal formulation of onabotulinumtoxinA (“Liposomal BoNT-A,” Lipella Pharmaceuticals) shows promise as a safe and effective treatment for refractory overactive bladder (OAB), according to a pilot study presented at the European Association of Urology annual congress in Stockholm, Sweden.
AUA Exhibit Hall Highlights: Orlando 2014
April 2nd 2014This guide features products and services from manufacturers that are exhibiting at the AUA annual meeting in Orlando. Exhibit hall booth numbers have been included so that you can search for product demonstrations and exhibits that are of particular interest to you.
PVP laser enabling BPH treatment for more patients
March 25th 2014Laser photoselective vaporization prostatectomy is permitting surgical intervention for BPH in a widening array of patients, many of whom harbor comorbidities that would ordinarily exclude them from invasive procedures, according to a new multinational report.
CMS issues two codes for BPH implant procedure
March 20th 2014The Centers for Medicare & Medicaid Services has issued two new codes that describe the UroLift implant procedure for the treatment of enlarged prostate in the April 2014 Update of the Hospital Outpatient Prospective Payment System (OPPS).
Prolapse, SUI treatments found largely equivalent
March 17th 2014For women undergoing surgery for vaginal prolapse and stress urinary incontinence, neither sacrospinous ligament fixation nor uterosacral ligament vaginal vault suspension was superior to the other for functional or adverse event outcomes, according to a recent study.
Physical activity may reduce women’s stone risk
December 18th 2013Postmenopausal women may reduce their risk of incident kidney stone disease by engaging in even mild physical activity and avoiding excessive caloric intake, analyses of data collected in the Women’s Health Initiative (WHI) Observational Study show.
High HgbA1c levels, caloric intake boost stone risk
December 18th 2013Two separate studies provide insight into a pair of factors-diabetes and changes in the American diet-that may boost the risk of kidney stone formation, including the formation of certain stone subtypes. A third study, meanwhile, suggests that medical professionals who work in operating rooms face a higher risk of stones, possibly because of high stress and low fluid intake.
Urinary tract infection agent yields positive phase III study results
December 2nd 2013Ceftolozane/tazobactam, an investigational antibiotic, showed positive top-line results in a pivotal phase III clinical trial of the drug’s use in complicated urinary tract infections, Cubist Pharmaceuticals, Inc. reported.
New Urology Products and Services November 2013
October 29th 2013The latest products and services from SuperSonic Imagine, Auxilium Pharmaceuticals, VIVUS, the Centers for Medicare & Medicaid Services, Innovus Pharmaceuticals, Buffalo Filter, KRS Global Biotechnology, Demos Health, and Ethicon Endo-Surgery.
Do ‘urine drop-offs’ make sense in your practice?
October 16th 2013In this article, I examine and question the phenomenon of “the urine drop-off”-having the patient with suspected UTI collect a urine sample at home and drop it off at the practice-in the context of best clinical practice, common sense, and basic office efficiency.